Skip to main content

Table 2 Adjusted time-trend regression results

From: Trends in the prevalence of thrombocytopenia among individuals iInfected with hepatitis C Virus in the United States, 1999-2008

 

HCV-Confirmed Patients (n = 467)

Variable

Model 1

n = 465

OR (95% CI)

Model 2

n = 449

OR (95% CI)

Model 3

n = 440

OR (95% CI)

Time

1.16 (0.82-1.64)

1.24 (0.84-1.84)

1.40 (0.88-2.22)

Age (years)

 

1.05 (1.02-1.08)

1.02 (1.02-1.12)

Male gender

 

2.87 (0.97-8.51)

1.45 (0.30-6.94)

Weight (kg)

 

0.99 (0.96-1.02)

0.99 (0.95-1.04)

Race/ethnicity (vs White)

   

   Black/African-American

 

1.26 (0.47-3.37)

0.50 (0.10-2.52)

   Hispanic

 

1.19 (0.38-3.72)

0.94 (0.27-3.30)

   Other

 

1.18 (0.13-11.06)

1.09 (0.17-7.00)

Albumin

  

0.28 (0.04-2.21)

ALT

  

1.01 (0.99-1.03)

AST

  

1.01 (0.99-1.03)

Blood urea nitrogen

  

0.92 (0.84-1.01)

Total calcium

  

0.18 (0.02-2.23)

Bilirubin

  

1.05 (0.99-1.13)

Hemoglobin

  

1.07 (0.73-1.56)

White blood cell count

  

0.59 (0.73-1.56)

Model c-statistic

0.48

0.74

0.89

  1. HCV = hepatitis C virus; OR = odds ratio; CI = confidence interval; ALT = alanine aminotransferase; AST = asparate aminotransferase